Methylenetetrahydrofolate reductase polymorphisms C677T and A1298C as maternal risk factors for Down syndrome in Jordan

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 1-2, 2011, Pages 51-57

  Sadiq, May F ^a   Al Refai, Ekhlas A ^a   Al Nasser, Amjad ^a   Khassawneh, Mohammad ^b   Al Batayneh, Qasem ^c  

^a YARMOUK UNIVERSITY   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c Princess Rahmah Teaching Hospital   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; JORDAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; DOWN SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; JORDAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RISK FACTORS;

EID: 79951993639     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0057     Document Type: Article

References (58)

1. Abu-Amero KK, Wyngaard CA, Dzimiri N (2003) Prevalence and role of methylenetetrahydrofolate reductase 677c>t and 1298a>c polymorphisms in coronary artery disease in Arabs. Arch Pathol Lab Med 127:1349-1352. (Pubitemid 37248335)
2. Acacio G, Barini R, Bertuzzo C, et al. (2005) Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21. Prenat Diagn 25:1196-1199. (Pubitemid 43164739)
3. Adkins RL, Radke K, Hunt PA (1997) Lack of checkpoint control at the metaphase/anaphase transition: a mechanism of meiotic nondisjunction in mammalian females. J Cell Biol 139:1611-1619. (Pubitemid 28079227)
4. Al-Gazali LI, Padmanabhan R, Melynk P, et al. (2001) Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with DS and neural tube defect. Am J Med Genet 103:128-132.
5. Al-Refai EA, Sadiq MF, Khasawneh M, et al. (2009) Effect of methotrexate on the survival of human lymphocyte cultures carrying MTHFR 677 (C>T) and MTHFR 1298 (A>C) Mutat Drug Chem Toxicol 32:103-107.
6. Amouzou EK, Chabi NW, Adjalla CE, et al. (2004) High prevalence of hyper homocysteinemia related to folate deficiency and the 677C3Tmutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am J Clin Nutr 79:619-624. (Pubitemid 41103906)
7. Andreassi MG, Botto N, Cocci F, et al. (2003) Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112:171-177. (Pubitemid 36869100)
8. Anello G, Guéant-Rodriguez RM, Bosco P, et al. (2004) Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 15:859-861. (Pubitemid 38453474)
9. Antonarakis SE (1998) Down syndrome. In: Jameson JL (ed) Principles of Molecular Medicine. Humana Press Inc., Totowa, NJ, pp 1069-1078.
10. Bi XH, Zhao HL, Zhang ZX, et al. (2009) Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiol Aging 30:1601-1607.
11. Boduroglu K, Alanay Y, Koldan B, et al. (2004) Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women. Am J Med Genet 127:5-10. (Pubitemid 38937198)
12. Bolufer P, Barragan EM, Collado J, et al. (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30:1471-1491. (Pubitemid 44573473)
13. Boxmeer JC, Macklon NS, Lindemans J, et al. (2009) IVF outcomes are associated with biomarkers of the homocysteine pathway in monofollicular fluid. Hum Reprod 24:1059-1066.
14. Castro R, Rivera I, Ravasco P (2004) 5,10- methylenetetahydrofolate reductase (MTHFR) 677C>T and1298A>C mutations are associated with DNA hypomethlation. J Med Genet 41:454-458. (Pubitemid 38788042)
15. Castro R, Rivera I, Struys EA, et al. (2003) Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49:1292-1296. (Pubitemid 36900615)
16. Chango A, Fillon-Emery N, Mircher C, et al. (2005) No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers. Br J Nutr 94:166-169. (Pubitemid 41357786)
17. Cyril C, Rai P, Chandra N, et al. (2009) MTHFR Gene variants C677T, A1298C and association with Down syndrome: a case-control study from South India. Ind J Hum Genet 15:60-64.
18. Epstein CJ (2001) Down syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, Vol. 1, 8th edition. McGraw-Hill, NewYork, pp 1223-1256.
19. Franco RF, Araujo AG, Guerreiro JF, et al. (1998) Analysis of the 677C→T mutation in the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 79:119-121. (Pubitemid 28037069)
20. Friso S, Choi S, Girelli D, et al. (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606-5611. (Pubitemid 34411596)
21. Frosst P, Blom HJ, Milos R, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
22. Gueant JL, Anello G, Bosco P, et al. (2005) Homocysteine and related genetic polymorphism in Down syndrome IQ. J Neurol Neurosurg Psych 76:706-709. (Pubitemid 40569683)
23. Haggarty P, McCallum H, McBain H, et al. (2006) Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet 367:1513-1519.
24. Hassold T, Hunt P (2001) To err (meiotically) is human: the genesis of human aneuploidy. (Review) Nat Rev Genet 2:280-291. (Pubitemid 33674776)
25. Hassold T, Sherman S. (2000) Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clin Genet 57:95-100. (Pubitemid 30116586)
26. Hobbs CA, Sherman SL, Yi P, et al. (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down Syndrome. Am J Hum Genet 67:623-630. (Pubitemid 30659593)
27. Homberger A, Linnebank M, Winter C, et al. (2000) Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet 8:725-729.
28. James S, Pogribna M, Pogribny I, et al. (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495-501. (Pubitemid 29463443)
29. Jennings BA, Willis GA, Skinner J, et al. (2010) Genetic selection? A study of individual variation in the enzymes of folate metabolism. BMC Med Genet 11:18-23.
30. Kang SS, Wong P, Susmano A, et al. (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545. (Pubitemid 21903052)
31. Kohli U, Arora S, Kabra M, et al. (2008) Prevalence of MTHFR C677T polymorphism in north Indian mothers having babies with Trisomy 21 Down syndrome. Downs Syndr Res Pract 12:133-137.
32. Kono S, Chen K (2005) Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci 96:535-542. (Pubitemid 41488416)
33. Lin D,. Li HW, Tan X, et al. (2007) Genetic polymorphisms in folate metabolizing enzymes and risk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer development. Forum Nutr 60:140-145.
34. Markan S, Sachdeva M, Sehrawat BS, et al. (2007) MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem 302:125-131. (Pubitemid 47202328)
35. Martínez-Frías ML (2008) The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome. Am J Med Genet Part A 146A:1477-1482.
36. Meguid NA, Dardir AA, Khass M, et al. (2008) MTHFR genetic polymorphism as a risk factor in Egyptian mothers with Down syndrome children. Dis Markers 24:19-26. (Pubitemid 350176507)
37. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
38. Molloy AM, Brody LC, Mills JL, et al. (2009) The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res A Clin Mol Teratol 85:285-294.
39. Mornet E, Muller F, Lenvoise-Furet A et al. (1997) Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514. (Pubitemid 28072347)
40. Mukherjee M, Joshi S, Bagadi S, et al. (2002) A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 61:155-159. (Pubitemid 36372622)
41. Mutchinick OM, López MA, Luna L, et al. (1999) High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defect. Mol Genet Metab 68:461-467. (Pubitemid 30043552)
42. O'Leary V, McDermott A, Molloy A, et al. (2002) MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 107:151-155.
43. Papapetrou C, Lynch SA, Burn J, et al. (1996) Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58. (Pubitemid 26237251)
44. Petersen MB, Mikkelsen M (2000) Nondisjunction in trisomy 21: origin andmechanisms. Cytogenet Cell Genet. 91:199-203 (review).
45. Rai A, Singh S, Mehta S, et al. (2006) MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. J Hum Genet 51:278-283.
46. Rosenblatt DS, Fenton WA (2001) Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th edition. McGraw Hill, New York, pp 3897-3933.
47. Sabbagh AS, Mahfoud Z, Taher A, et al. (2008) High prevalence of MTHFR gene A1298C polymorphism in Lebanon. Genet Test 12:75-80. (Pubitemid 351457789)
48. Schupf N, Kapell D, Nightingale B, et al. (2001) Specificity of the five fold increase in AD in mothers of adults with Down syndrome. Neurology 57:979-984. (Pubitemid 32880189)
49. Sheth J, Sheth F (2003) Gene polymorphism and folate metabolism: a maternal risk factor for Down syndrome. Indian Pediatr 40:115-123. (Pubitemid 36253961)
50. Skibola CF, Forrest MS, Coppede F, et al. (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104:2155-2162. (Pubitemid 39297871)
51. Smulders YM, Stehouwer CD (2005) Folate metabolism and cardiovascular disease. Semin Vasc Med 5:87-97. (Pubitemid 40944285)
52. Speer MC, Warley G, Mackey JF, et al. (1997) The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defects in American Caucasians. Neurogenetics 1:149-150. (Pubitemid 127709623)
53. Trabetti E (2008) Homocysteine, MTHFR gene polymorphisms and cardio-cerebrovascular risk. J Appl Genet 49:267-282.
54. Van der Put NM, Steegers-Theunissen RPM, et al. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
55. Van der Put NM, Van Straaten HW, Trijbels FJ, et al. (2001) Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 226:243-270. (Pubitemid 32520289)
56. Van der Put NMJ, Gabreels F, Stevens EMB, et al. (1998) A second common mutation in the methylenetetrahydrofolate redutase gene: an additional risk factor for neural - tube defects? Am J Hum Genet 62:1044-1051.
57. Weisberg I, Tran P, Christensen B (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet 64:169-172. (Pubitemid 28453294)
58. Wetkamp LR, Tackels DC, Hunter AGW, et al. (1998) Heterozygote advantage of the MTHFR gene in patients with neural-tube defects and their relatives. Lancet 351:1554-1555. (Pubitemid 28230893)